Aethlon Medical のニュースと活動
役員
8人の主要幹部と一緒に組織図を見る
Aethlon Medicalでもっとも検索された略歴
- Jim Frakes, Interim Chief Executive Officer, Chief Financial Offic...
- Angela Rossetti, Director
- Edward Broenniman, Chairman of the Board
アラートを作成
Aethlon Medical のエグゼクティブの異動をフォローします。
バイオテクノロジー
Aethlon MedicalはIncyte (アメリカ合衆国（米国）),Anthos Therapeutics (アメリカ合衆国（米国）),Valneva (フランス共和国)を含む2,347の競合企業を有します。
Popular M&A news in バイオテクノロジー
- Synaptogenix将改名为TAO Synergies。 (2025年7月3日に公開).
- AbbVie has announced the acquisition of Capstan Therapeutics (2025年7月1日に公開).
- ％sは、％s百万ドルの資金調達を発表しました。 (2025年6月30日に公開).
バイオテクノロジー業界でのその他のコンタクトの提案
ニュース
％sによる最新のプレスリリース
- Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu
- Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
- Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
- Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
- Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
- Aethlon Medical to Present at Virtual Investor Conferences in September
- Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
- Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
- View more press releases Close
％sについてのソーシャルメディア
- Aethlon Medical についてのウィキペディア,Google News & Yahoo Financeの記事
- Aethlon Medical についてのLinkedIn,ツイッター & YouTubeの記事
